Search

everythinglearnresearchcommunity

for

Search:↓

Botulinum toxin shows promise for various skin conditions but requires more research for confirmation and standardized use.

Some skin conditions may indicate metabolic syndrome, which could help with early detection and management of related health issues.

Certain microRNAs in the fluid around eggs are linked to Polycystic Ovary Syndrome and may help diagnose it.

A boy with severe Vitamin D-resistant rickets did not respond to treatment and lacked a common symptom, suggesting a need for alternative treatments.

The document concludes that more research is needed to understand how to treat muscle pain with drugs.

Microneedles offer a promising, painless way to treat skin diseases but need improvements for better use.

Regenerative pharmacology, which combines drugs with regenerative medicine, shows promise for repairing damaged body parts and needs more interdisciplinary research.

The document concludes that more research is needed to understand excessive hair growth in women with normal hormone levels and regular ovulation.

People with polycystic ovary syndrome may have a higher risk of heart problems due to abnormal nervous system control of their heart and blood pressure.

Minoxidil works in liver and outer hair root sheath for hair growth.

Testosterone therapy is generally safe for transmen, improves sexual function, and has manageable health risks with proper monitoring.

Gonadal dysgenesis, like Turner's and Klinefelter's syndromes, negatively affects bone health, but hormone treatments can help.

Fractional laser resurfacing is effective and safe for skin treatment, with benefits like less downtime and a low risk of adverse events.

Accurate diagnosis is key for treating different kinds of hair loss, and immune response variations may affect the condition and treatment results.

FAGA diagnosis uses blood tests and trichoscopy, with treatments like topical minoxidil, oral anti-androgens, and hormone-modulating drugs.

Female pattern hair loss has unclear causes, possibly involving genetics, hormones, and environment, and needs better treatments.

Hormonal therapies are safe and effective for treating adult women's acne.

Cyproterone acetate is effective for treating hirsutism and acne but less so for hair loss, with side effects similar to birth control pills.

Drug repurposing is a cost-effective way to find new uses for existing drugs, speeding up treatment development.

PRP therapy increases hair density for androgenetic alopecia.

Hirsutism can be caused by various conditions besides PCOS, and it's important to treat the underlying issue and manage symptoms with medication and cosmetic approaches.

Finasteride and CPA-EE2 equally reduce hirsutism, but affect hormone levels differently.

The document suggests that clinical trials for PCOS should focus on meaningful primary outcomes like live birth rates, rather than less reliable surrogate markers.

Autoimmune diseases can cause hair loss, and early treatment is important to prevent permanent damage.

New treatments for PCOS show promise, but no current medication treats all aspects of the condition.

Epilepsy and certain epilepsy drugs can lead to reproductive problems in women, but changing medication might improve these issues.

Using a special stem cell formula on the scalp once a month for six months helped people with hair loss grow more hair.

Using hyaluronic acid fillers and laser together is generally safe and effective for facial rejuvenation, but careful planning is needed.

Platelet-Rich Plasma (PRP) shows promise for treating various skin conditions, but more research is needed to standardize its use.

High afamin levels are linked to metabolic syndrome and may predict its development in women with insulin resistance.